Bank of America’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.9M Buy
524,772
+163,062
+45% +$4.32M ﹤0.01% 2511
2025
Q1
$8.74M Buy
361,710
+159
+0% +$3.84K ﹤0.01% 2785
2024
Q4
$14.5M Sell
361,551
-61,282
-14% -$2.47M ﹤0.01% 2206
2024
Q3
$26.8M Sell
422,833
-7,949
-2% -$503K ﹤0.01% 1841
2024
Q2
$22.8M Buy
430,782
+18,367
+4% +$974K ﹤0.01% 1851
2024
Q1
$33.8M Sell
412,415
-358,208
-46% -$29.4M ﹤0.01% 1556
2023
Q4
$14.3M Buy
770,623
+78,349
+11% +$1.46M ﹤0.01% 2081
2023
Q3
$7.66M Buy
692,274
+287,508
+71% +$3.18M ﹤0.01% 2526
2023
Q2
$6.56M Sell
404,766
-385,079
-49% -$6.24M ﹤0.01% 2652
2023
Q1
$13.2M Buy
789,845
+692,945
+715% +$11.5M ﹤0.01% 2179
2022
Q4
$911K Sell
96,900
-20,880
-18% -$196K ﹤0.01% 4272
2022
Q3
$320K Sell
117,780
-3,081
-3% -$8.37K ﹤0.01% 4939
2022
Q2
$349K Buy
120,861
+70,298
+139% +$203K ﹤0.01% 4971
2022
Q1
$152K Sell
50,563
-4,058
-7% -$12.2K ﹤0.01% 5862
2021
Q4
$251K Sell
54,621
-237,961
-81% -$1.09M ﹤0.01% 5562
2021
Q3
$1.84M Buy
292,582
+14,839
+5% +$93.2K ﹤0.01% 3867
2021
Q2
$1.66M Sell
277,743
-111,343
-29% -$667K ﹤0.01% 3869
2021
Q1
$2.46M Buy
389,086
+138,468
+55% +$876K ﹤0.01% 3579
2020
Q4
$1.41M Sell
250,618
-49,300
-16% -$278K ﹤0.01% 3647
2020
Q3
$1.75M Buy
299,918
+2,905
+1% +$16.9K ﹤0.01% 3319
2020
Q2
$2.14M Buy
297,013
+16,054
+6% +$116K ﹤0.01% 3181
2020
Q1
$1.31M Buy
280,959
+13,080
+5% +$61.2K ﹤0.01% 3386
2019
Q4
$2.15M Sell
267,879
-46,271
-15% -$371K ﹤0.01% 3407
2019
Q3
$2.16M Sell
314,150
-234,445
-43% -$1.61M ﹤0.01% 3385
2019
Q2
$4.56M Sell
548,595
-351,419
-39% -$2.92M ﹤0.01% 2849
2019
Q1
$8.95M Buy
900,014
+647,405
+256% +$6.43M ﹤0.01% 2249
2018
Q4
$1.93M Buy
252,609
+242,296
+2,349% +$1.85M ﹤0.01% 3334
2018
Q3
$180K Sell
10,313
-173
-2% -$3.02K ﹤0.01% 4838
2018
Q2
$100K Sell
10,486
-5,790
-36% -$55.2K ﹤0.01% 5072
2018
Q1
$71K Buy
+16,276
New +$71K ﹤0.01% 5170